NCT04157413

Brief Summary

This study will be comprised of 2 phases. Phase 1 study is a comparative cross-sectional study which will be conducted among children aged 12-24 months living in agricultural area. A total of 172 healthy children consisted of 86 stunted children (Length for age z-score \<-2 Standard deviation) and 86 non-stunted children (Length for age z-score ≥0.5 Standard Deviation) will be recruited. Dietary intake, urine and dried blood spot from finger prick will be collected to assess amino acid intake, intestinal permeability and essential blood amino acid respectively. Qualitative study i.e. focus group discussion (FGD) and market survey will also be implemented. According to the result of phase 1 study, 2 types of food-based approaches will be developed, namely Complementary food recommendations (CFR) and Food multi-mix formula

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
172

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 2, 2020

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

November 8, 2019

Status Verified

November 1, 2019

Enrollment Period

29 days

First QC Date

November 6, 2019

Last Update Submit

November 6, 2019

Conditions

Keywords

amino acid intakeblood amino acidstuntinglinear growthintestinal permeabilitylactulose mannitol ratio

Outcome Measures

Primary Outcomes (3)

  • Amino acid intake

    Amino acid intake will be assessed by estimated food record

    January - February 2020

  • Blood amino acid

    Essential blood amino acid will be measured from finger prick dried blood spot and will be analyzed using LC-MS/MS

    January - April 2020

  • Intestinal Permeability

    Intestinal permeability will be measured from urine and will be analyzed using HPLC

    January-April 2020

Other Outcomes (1)

  • Linear growth

    December 2019

Study Arms (2)

Stunted Group

A comparative cross sectional study will compare stunted group and non-stunted group on amino acid intake, blood amino acid and intestinal permeability. Stunted group is defined as children who have LAZ \<-2 SD

Non-stunted Group

Non-stunted group will be those with LAZ \>= 0.5 SD matching by age and sex with stunted group. Other criteria will be similar. No Intervention will be given to the groups in this proposed protocol.

Eligibility Criteria

Age12 Months - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Target population of this study are children 12-24 months living in rural agricultural area in Kabupaten Malang. Kecamatan will be chosen based on the high prevalence of stunting and having potentials of protein food source to be optimized. Sample of the study are children living in selected villages in the period of 2019-2020 who fulfill the inclusion criteria.

You may qualify if:

  • Stunting group is defined as length for age Z-score (LAZ) \<-2.0 SD and non-stunting group as LAZ ≥-0.5 SD
  • Normal weight for length Z-score (WLZ ≥-2 SD to ≤+1 SD)
  • Group matching by age, gender
  • Singleton
  • Full term gestation
  • Normal birth weight
  • Living with mother
  • Not suffered from diarrhea at least in the last 1 month (as reported by the mothers)
  • Not suffering from fever during assessment (as measured by the health staff)
  • Not born from diabetic mothers (as reported by the mothers)

You may not qualify if:

  • Drink Ultra High Temperature (UHT) milk at least 15 days before urine collection
  • Taking any medication.
  • Had taken non-steroidal anti-inflammatory drugs within two weeks of the study,
  • Taken antibiotics within 4 weeks of the study,
  • Unable to drink the sugar solution
  • Refuse to participate until completion of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Growth Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Badriul S Hegar, Prof

    Indonesia University

    STUDY CHAIR

Central Study Contacts

Nia N Wirawan, MSc.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 6, 2019

First Posted

November 8, 2019

Study Start

January 2, 2020

Primary Completion

January 31, 2020

Study Completion

April 30, 2020

Last Updated

November 8, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

I will not share the IPD of the subject participated due to consent issue